Key Takeaways
- Lissun, a health-tech platform for children with special needs, has secured Rs 48 crore in Series A funding led by Colossa Ventures.
- The funding will support the expansion of its Sunshine by LISSUN centres and enhance AI-driven solutions.
- Founded in 2021, Lissun aims to improve access to developmental care, currently conducting over 10,000 therapy sessions monthly across 25 centres.
Funding Round and Growth Plans
Lissun, a Gurugram-based health-tech startup focused on children’s developmental needs, has raised Rs 48 crore in a Series A funding round led by Colossa Ventures. This round also saw investments from Physis Capital, RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures, and SucSEED Ventures, alongside new investors New Age India Fund and Beyond Capital Ventures.
This significant capital injection will enable Lissun to expand its network of Sunshine by LISSUN centres in major cities, develop advanced AI-driven solutions, and enhance its clinical processes. Previously, the startup raised $2.5 million in a pre-Series A funding round led by RPSG Capital Ventures in September 2024, followed by Rs 2.77 crore in funding from Zerodha and other investors earlier this year.
Founded in 2021 by Krishna Veer Singh and Tarun Gupta, Lissun has quickly become a key player in India’s healthcare sector for special needs children. Offering child development centres and digital products, Lissun reports a fourfold growth over the past year, conducting over 10,000 therapy sessions monthly across its 25 centres. The company plans to increase its physical presence to 50 centres by next year, aiming to reach over a million children through its digital offerings.
As the need for high-quality developmental and behavioral care for children in India grows, Lissun is addressing this necessity through its innovative approach. The startup offers an AI-enhanced ecosystem that connects children with skilled therapists both in-centre and online.
Lissun operates in a competitive landscape, vying with other platforms like Butterfly Learnings, Continua Kids, Hoola Health, and Amaha’s Children First. The health-tech sector focused on special needs care is expanding, as evidenced by recent funding rounds—in 2024, Butterfly Learnings raised Rs 32 crore, while Hoola Health secured $5 million in 2026.
The landscape indicates a rising demand for specialized care solutions for conditions like autism, ADHD, speech, and language disorders. By bridging the gap in accessible, high-quality care, Lissun aims to make a significant impact in the lives of children with developmental delays.
The content above is a summary. For more details, see the source article.
